CLIA EXOME

Welcome to the Brand page for “CLIA EXOME”, which is offered here for Medical testing, for diagnostic or treatment purposes;dna analysis services for research or medical purposes, dna sequencing services, analyzing dna sequences for genetic variations across different sample populations, correlating dna sequence variations of sample populations with data indicating effectiveness of medical treatment of the populations, screening dna sequences to determine the presence or absence of genetic variations that correlate to effectiveness of a proposed medical treatment, confirming or establishing a genetic disorder, mendelian disease gene discovery, and dna analysis services under clinical laboratory improvement amendments (clia) certification standards; medical testing, performing exome sequencing services for researchers performing work in connection with human diseases;.

Its status is currently believed to be active. Its class is unavailable. “CLIA EXOME” is believed to be currently owned by “AMBRY GENETICS CORPORATION”.